title: A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfates.
abstract: Within cells, dermatan sulfate (DS) and heparan sulfate (HS) are degraded in two steps. The initial endohydrolysis of these polysaccharides is followed by the sequential action of lysosomal exoenzymes to reduce the resulting oligosaccharides to monosaccharides and inorganic sulfate. Mucopolysaccharidosis (MPS) type II is a lysosomal storage disorder caused by a deficiency of the exoenzyme iduronate-2-sulfatase (I2S). Consequently, partially degraded fragments of DS and HS have been shown to accumulate in the lysosomes of affected cells and are excreted in the urine. Di- to hexadecasaccharides, isolated from the urine of a MPS II patient using anion exchange and gel filtration chromatography, were identified using electrospray ionization-tandem mass spectrometry (ESI-MS/MS). These oligosaccharides were shown to have non-reducing terminal iduronate-2-sulfate residues by digestion with recombinant I2S. A pattern of growing oligosaccharide chains composed of alternating uronic acid and N-acetylhexosamine residues was identified and suggested to originate from DS. A series of oligosaccharides consisting of hexosamine/N-acetylhexosamine alternating with uronic acid residues was also identified and on the basis of the presence of unacetylated hexosamine; these oligosaccharides are proposed to derive from HS. The presence of both odd and even-length oligosaccharides suggests both endo-beta-glucuronidase and endo-N-acetylhexosaminidase activities toward both glycosaminoglycans. Furthermore, the putative HS oligosaccharide structures identified indicate that heparanase activities are directed toward regions of both low and high sulfation, while the N-acetylhexosaminidase activity acted only in regions of low sulfation in this polysaccharide.
authors.affiliation: Lysosomal Diseases Research Unit, Department of Genetic Medicine, Children, Youth and Women's Health Service, North Adelaide, SA 5006, Australia. maria.fuller@adelaide.edu.au
authors.forename: Maria
authors.initials: M
authors.lastname: Fuller
authors.forename: Ally
authors.initials: A
authors.lastname: Chau
authors.forename: Rachael C
authors.initials: RC
authors.lastname: Nowak
authors.forename: John J
authors.initials: JJ
authors.lastname: Hopwood
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Meikle
mesh_terms: D002236:Carbohydrate Conformation; D002240:Carbohydrate Sequence; D002853:Chromatography, Liquid; D003871:Dermatan Sulfate / Q000737:chemistry / Q000652:urine*; D005260:Female; D006023:Glycoproteins / Q000737:chemistry / Q000172:deficiency; D006497:Heparan Sulfate / Q000737:chemistry / Q000652:urine*; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D016532:Mucopolysaccharidosis II / Q000201:enzymology / Q000235:genetics / Q000652:urine*; D009844:Oligosaccharides / Q000737:chemistry / Q000652:urine*; D021241:Spectrometry, Mass, Electrospray Ionization; D014574:Uronic Acids / Q000652:urine
chemical_list: D003871:Dermatan Sulfate; D006023:Glycoproteins; D006497:Heparan Sulfate; D009844:Oligosaccharides; D014574:Uronic Acids; C018322:IDS protein, human